Summary

The purpose of this study is to assess the validity and usefulness of omics signatures for improved identification and risk stratification of patients with endocrine hypertension and stratification of patients with primary hypertension.

Study Name: Omics Signature in the Diagnosis of Hypertension
Status: Unknown
Conditions: Hypertension
Interventions: Other: omics
Locations: European Georges Pompidou Hospital, Paris, France|University of Padua, Padua, Italy; University of Torino, Torino, Italy; Raddboudumc, Nijmegen, Gelderland, Netherlands; University of Glasgow, Glasgow, United Kingdom
Study link: https://ClinicalTrials.gov/show/NCT02772315

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.